OmniAb (OABI) Non Operating Investment Income (2022)
OmniAb (OABI) posted quarterly Non Operating Investment Income of $1.1 million for Q3 2022, up 267.13% quarter-over-quarter from $297047.0 in Q2 2022.
Powered by 
Analysis
OmniAb (OABI) Non Operating Investment Income (2022) Analysis & Trends
OmniAb (OABI) has reported Non Operating Investment Income for 1 consecutive years, with $1.1 million the latest figure, recorded in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.21 Bn | 132.36 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.73 Bn | 58.55 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.59 Bn | 52.46 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 40.13 Bn | 35.04 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.55 Bn | 32.24 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.60 Bn | 27.77 Bn | - | - |
| 9 | Insmed | 27.70 Bn | 26.54 Bn | 358.27 Mn | - |
| 10 | OmniAb | 582.80 Mn | 530.80 Mn | 12.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 297,047.00 |
| Mar 31, 2022 | 51,285.00 |